| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3853011 | Diálisis y Trasplante | 2007 | 6 Pages |
Abstract
Our data suggest that, in addition to reducing PTH levels in uremic patients with SHPT, cinacalcet modifies bone remodeling with a tendency to reduce levels of beta-crosslap and osteocalcin.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Omar Haouari, José Manuel Osorio, Rafael J. Esteban, Fernando Perán, Juan Bravo, Concha Asensio,